DocWire News Editors

DocwireNews

Matt Hancock, British Secretary of State for Health and Social Care, recently announced his goal to sequence 5 million genomes in the UK in the next 5 years. Where deemed fit, patients will be asked for their consent to have their genome sequenced and analyzed by scientists. Researchers will use this data to enhance development of new treatments and tests for many diseases.Starting in 2019, children with serious illnesses suspected to be genetic disorders will be offered genomic sequencing as part of their healthcare. Adults with similar uncommon diseases and complex cancers will be offered this option as well, with the aim being to identify genetic links to these problematic conditions. The ambitious effort to sequence 5 million genomes will be supplemented by expertise provided by experts like UK Research and Innovation, the NHS, and others.The NHS Genomic Medicine Service plans to expand on existing projects, such as the 100,000 Genomes Project, and have 1 million whole genomes sequenced by both the NHS and research project UK Biobank in the coming 5 years. These national efforts will greatly aid Hancock in reaching his unprecedented goal of having 5 million genomes sequenced in 5 years.<div id="attachment_4800352" style="width: 220px" class="wp-caption alignright"><img aria-describedby="caption-attachment-4800352" loading="lazy" decoding="async" class=" td-modal-image wp-image-4800352 size-full" src="https://mumcdnstorage.blob.core.windows.net/dwnews/2018/10/hancock.jpg" alt="hancock" width="210" height="200">
Health and Social Care Secretary, Matt Hancock
</div>&ldquo;I&rsquo;m proud to announce we are expanding our 100,000 Genomes Project so that one million whole genomes will now be sequenced by the NHS and the UK Biobank,&rdquo; said Hancock (pictured to right). &ldquo;I&rsquo;m incredibly excited about the potential for this type of technology to improve the diagnosis and treatment for patients to help people live longer, healthier lives &ndash; a vital part of our long-term plan for the NHS.&rdquo;Currently, diagnosis of rare diseases can take years in some cases, potentially leading to fatalities that could have been prevented with earlier diagnosis. With this massive genomic project, researchers in the UK will have a large bank of genomic data to use in linking genetic abnormalities to harmful diseases, hopefully leading to prevention and protection against these conditions.&ldquo;The more genetic information there is, the earlier clinicians can predict, diagnose and treat the illness in a way that works best for each patient,&rdquo; reads the statement released by the Department of Health and Social Care on Tuesday.Hancock hopes to achieve his lofty goal with support from powerful genomics firms in the UK. Genomics England Chief Scientist, Professor Mark Caulfield, expressed his optimism in stating, &ldquo;Genomics England welcomes this ambitious new vision for genomics, which assures the UK will continue to be the global leader in the application of genomic medicine. As the UK database expands to 5 million sequences and beyond, new insights will help to save many lives, both in the NHS and around the world.&rdquo;Marc Stapley, Executive Vice President of Strategy and Corporate Development at Illumina (one of Genomics England&rsquo;s sequencing partners) also chimed in, saying, &ldquo;As the industrial partner of Genomics England for the 100,000 Genomes Project, Illumina supports the scale and vision of the UK government in its endeavors to place genomic medicine as one of the pillars of healthcare.&ldquo;<blockquote class="twitter-tweet" data-lang="en">
The UK will sequence 5 million genomes in the next 5 years, building on existing initiatives like the 100,000 Genomes Project. Patients will be asked to consent to their genome data being used to develop treatments for diseases including cancer.<a href="https://t.co/Naj4Hcxgma">https://t.co/Naj4Hcxgma</a>
&mdash; Future Advocacy (@FutureAdvocacy) <a href="https://twitter.com/FutureAdvocacy/status/1047808741419241473?ref_src=twsrc%5Etfw">October 4, 2018</a>
</blockquote><script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script>Sources: <a href="https://www.gov.uk/government/news/matt-hancock-announces-ambition-to-map-5-million-genomes">Gov.UK</a>,&nbsp;<a href="https://www.genomicsengland.co.uk/matt-hancock-announces-5-million-genomes-within-five-years/">Genomics England</a>

Bradley Marder, MD

Joel M. Topf, MD, FACP

Gout Studies: Transplant Waitlisting and Bone Erosion

NKF Spring Clinical Meetings 2025

Jayme Locke, MD, MPH

The Promise of Xenotransplantation

Leah Lawrence

Real-World Data Backs Invasive DFS as Surrogate Endpoint for OS in EBC

HR Breast Cancer

Latest News

UK Government Goal: Sequence 5 Million Genomes Within 5 Years

Future of Medicine

Matt Hancock, British Secretary of State for Health and Social Care, recently announced his goal to sequence 5 million genomes in the UK in the next 5 years. Where deemed fit, ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe